Argenx soars on CIDP shot approval

Go back to Argenx soars on CIDP shot approval

argenx SE (ARGX) PT Raised to $512 at Citi

June 24, 2024 2:08 PM EDT

Citi analyst Samantha Semenkow raised the price target on argenx SE (NASDAQ: ARGX) to $512.00 (from $463.00) while maintaining a Buy rating.

The analyst comments "ARGX shares are up following the approval of Vyvgart Hytrulo in CIDP, reflecting the markets optimism into the... More